Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2025-03-31 Regulatory Filings
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification from Ajooni Biotech Limited to the National Stock Exchange of India regarding the closure of the trading window in compliance with SEBI regulations ahead of the declaration of audited financial results for the quarter and year ended March 31, 2025. It is an announcement related to insider trading restrictions and timing around financial results disclosure, not the financial results report itself. The document is short (1788 characters) and serves as an intimation or regulatory announcement rather than containing financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS) as a compliance-related announcement.
2025-03-31 English
Integrated Filing- Financial
Regulatory Filings
2025-02-22 English
Updates
Board/Management Information Classification · 100% confidence The document is a letter addressed to the National Stock Exchange of India Ltd regarding an update on a previously submitted intimation about the appointment of an Independent Director. It provides an affirmation that the appointed director is not debarred from holding office, complying with a specific NSE circular. The content focuses on management/board information related to director appointment and compliance, without any financial data or report content. The document length is short (1501 characters), and it is not a report or announcement of a report publication. Therefore, it fits the category of Board/Management Information (MANG).
2025-02-18 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a compliance letter addressed to the National Stock Exchange of India Ltd regarding the newspaper publication of unaudited financial results for the quarter ended 31st December 2024. It references Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates the publication of quarterly financial results. The document is dated 14/02/2025 and includes a statement that the unaudited financial results have been published in newspapers. The content is an announcement of the publication of the quarterly financial results, not the financial report itself. The document length is 15,000 characters, but the content is primarily a notification of publication rather than the report containing substantive financial data or analysis. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Regulatory Filing (RNS) because it is a regulatory announcement of the publication of the quarterly financial results, not the interim/quarterly report itself.
2025-02-14 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a statement submitted to the National Stock Exchange of India regarding the deviation or variation in the utilization of funds raised through a Right Issue. It references Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides detailed tables showing the original allocation, modified allocation, funds utilized, and confirms no deviation or variation for the quarter ended December 31, 2024. The document is signed by the Managing Director and is a compliance disclosure about fund utilization rather than a full financial report or earnings release. It is not an annual or interim report, nor a call transcript or management discussion. It is a regulatory compliance filing specifically about fund utilization deviation or variation, which fits best under Regulatory Filings (RNS) as it does not constitute a full report but a regulatory statement.
2025-02-13 English
Outcome of Board Meeting
Regulatory Filings
2025-02-13 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.